Magnosco


Magnosco is a company focused on early-stage skin cancer detection. Magnosco develops a method for early stage malignant melanoma detection, known as dermatofluoroscopy. The non-invasive diagnostics are based on infrared laser and artificial intelligence technology.

Headquarters

Berlin, Germany

Employees

1-10

Links


Org chart

Lukasz Szyc
Director Medical Development
Collapse
Yohai Amir
Project Manager
Christoph Seifert
Lead Medical Device Development
Goran Stankovic
Entwicklungsingenieur

Teams

This company has no teams yet